Health Dictionary Find a Doctor

Carcinoma of the penis

For patient information, click here

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Swathi Venkatesan, M.B.B.S.[2]

Synonyms and keywords: Penile cancer, squamous cell cancer – penis, cancer of the penis, penile carcinoma, neoplasm of penis, malignant tumor of penis, cancer of penis, malignant penile tumor, malignant penile tumour, malignant tumour of penis, carcinoma of penis

Overview

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis is a malignant growth found on the skin or in the tissues of the penis. Carcinoma of the penis may be classified according to cell types into several subtypes: squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, and sarcoma. The incidence of carcinoma of the penis is approximately 1 per 100,000 men in the United States. On gross pathology, scaly patches or nodules, erythematous, and ulceration are characteristic findings of carcinoma of the penis. Common risk factors in the development of carcinoma of the penis are human papillomavirus, phimosis, poor genital hygiene, not being circumcised, weakened immune system, smoking, and treatment for psoriasis. And it is caused by an infection with human papillomavirus. The most common symptoms of carcinoma of the penis include non-healing lesion, change in the colour of the penis, redness or irritation of the penis, lump or thickening of the skin on the penis, phimosis, foul-smelling discharge or bleeding from the penis or from underneath the foreskin, itching or burning under the foreskin, swelling of the penis, lump in the groin, and dysuria. Biopsy is helpful in the diagnosis of carcinoma of the penis. The predominant therapy for carcinoma of the penis is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required. Prognosis is generally good, and the 5-year survival rate of patients with carcinoma of the penis is approximately 67%.

Classification

Carcinoma of the penis may be classified according to cell types into several subtypes including, squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, sarcoma.

Pathophysiology

Most types of penile cancer traditionally begin as small lesions, most commonly on the glans or prepuce. About 95% of penile cancers develop from flat, scale-like cells called squamous cells. squamous cell carcinoma (SCC) can develop anywhere on the penis, but most develop on the foreskin (in uncircumcised men) or the glans. This type of cancer is typically slow growing. When found early, it is often curable. On gross pathology, the glans and the foreskin are the most common locations to find scaly patches, nodules, palpable painless lump, erythematous, ulceration, concurrent phimosis may conceal the lesion, surface of the lesion may be exophytic, flat, or ulcerated, chronic penile rash or subtle burning sensation and swollen inguinal lymph nodes as characteristic findings of carcinoma of penis. On microscopic histopathological analysis, keratinization and intercellular bridges are characteristic findings of carcinoma of the penis. Penile cancer arises from precursor lesions, which generally progress from low-grade to high-grade lesions.

Epidemiology and Demographics

The incidence of carcinoma of the penis is approximately 1 per 100,000 males in the United States. The majority of cases are reported in less developed areas. The incidence of penile cancer increases with age; the diagnostic median age usually is 40 – 70 years, median age 58 years. Penile cancer is rare if circumcision is done at birth, and is more common in cases of late circumcision (after age 10). Carcinoma of the penis is more prevalent in populations with lower education and higher poverty. More commonly seen in Hispanic and African American men; familial cases have occasionally been reported.

Risk Factors

Common risk factors in the development of carcinoma of the penis include human papillomavirus, phimosis, poor genital hygiene, uncircumcised males, weakened immune system, smoking, and psoralen ultraviolet A (PUVA) therapy treatment for psoriasis.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for carcinoma of the penis.

Causes

Carcinoma of the penis is caused by an infection with human papillomavirus.

Differential Diagnosis

Carcinoma of the penis must be differentiated from condyloma acuminata, penile intraepithelial neoplasia (PeIN), balanitis xerotica obliterans, Buschke-Lowenstein tumour, Bowenoid papulosis, leukoplakia.

Prognosis

Prognosis of carcinoma of the penis is generally good, and the 5-year survival rate is approximately 67%. The prognosis varies with the stage of tumor; stages 0–II have the most favorable prognosis.

Staging

Carcinoma of the penis may be classified into several subtypes based on TNM system and UICC staging system.

History and Symptoms

The most common symptoms of carcinoma of the penis include any non-healing lesion, change in the colour of the penis, redness, irritation of the penis, lump, thickening of the skin on the penis, phimosis, foul-smelling discharge, bleeding from the penis or from underneath the foreskin.

Physical Examination

Common physical examination findings of carcinoma of the penis include weight loss, pallor, inguinal lymphadenopathy, non-healing ulcer on the penis, mass on the penis, phimosis, skin induration on the penis, change in the colour of the penis, erythema of the penis, foul-smelling discharge, bleeding from the penis or from underneath the foreskin, as well as swelling of the penis.

Laboratory Tests

Some patients with carcinoma of the penis may have elevated concentration of serum calcium, which is usually suggestive of bone metastases.

X Ray

There are no X-ray findings associated with carcinoma of the penis. X-ray may be performed to detect metastases of penile cancer to lungs and bones.

CT

CT scan may be performed to detect metastases of carcinoma of the penis to surrounding lymph nodes, liver, lungs, and other organs.

MRI

MRI may be performed to detect metastases of carcinoma of the penis to brain, spinal cord, and nearby organs and tissues.

Ultrasound

Ultrasound may be helpful in the diagnosis of the extent of carcinoma of the penis.

Other Imaging Findings

There are no other imaging findings associated with carcinoma of the penis.

Other Diagnostic Studies

There are no other diagnostic study findings associated with carcinoma of the penis.

Biopsy

Biopsy is helpful in the diagnosis of carcinoma of the penis.

Medical Therapy

The predominant therapy for carcinoma of the penis is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required.

Surgery

Surgery is the mainstay of treatment for carcinoma of the penis.

Primary Prevention

Effective measures for the primary prevention of carcinoma of the penis include circumcision, good personal hygiene, and safer sexual practices. Gardasil vaccine is recommended for men to prevent HPV infection.

Secondary Prevention

There are no secondary preventive measures available for carcinoma of the penis.

References


Template:WikiDoc Sources

Historical Perspective


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Swathi Venkatesan, M.B.B.S.[2] Sogand Goudarzi, MD [3]

Overview

Historical Perspective

History of Circumcision

History of HPV relation to Carcinoma of Penis

References

  1. Morris BJ, Kennedy SE, Wodak AD, Mindel A, Golovsky D, Schrieber L; et al. (2017). “Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy”. World J Clin Pediatr. 6 (1): 89–102. doi:10.5409/wjcp.v6.i1.89. PMC 5296634. PMID 28224100.
  2. Dunsmuir, W.D.; Gordon, E.M. (2002). “The history of circumcision”. BJU International. 83 (S1): 1–12. doi:10.1046/j.1464-410x.1999.0830s1001.x. ISSN 1464-4096.
  3. Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, Meijer CJ; et al. (2006). “Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival”. Int J Cancer. 119 (5): 1078–81. doi:10.1002/ijc.21961. PMID 16570278.

Template:WH Template:WS

Classification

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis may be classified according to cell types into several subtypes: squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, and sarcoma.

Classification

Most common malignant penile tumours

Squamous cell carcinoma[1][2][3]

  • There are several subtypes of SCC:[4]
  • Basaloid carcinoma
  • Sarcomatoid carcinoma
  • Fast growing

Rare malignant penile tumours

Adenocarcinoma“Penile Cancer: Introduction | Cancer.Net”.

Melanoma

  • Develops from skin cells called melanocytes
  • Usually develops on sun-exposed areas of skin, but sometimes develops on the penis

Basal cell carcinoma

Lymphoma

Sarcoma

References

  1. Malignant tumours of the penis. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/penile-cancer/malignant-tumours/?region=ab
  2. Cubilla AL, Velazquez EF, Amin MB, Epstein J, Berney DM, Corbishley CM; et al. (2018). “The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations”. Histopathology. 72 (6): 893–904. doi:10.1111/his.13429. PMID 29105175.
  3. Marchionne, Elizabeth; Perez, Caroline; Hui, Andrea; Khachemoune, Amor (2017). “Penile squamous cell carcinoma: a review of the literature and case report treated with Mohs micrographic surgery”. Anais Brasileiros de Dermatologia. 92 (1): 95–99. doi:10.1590/abd1806-4841.20175009. ISSN 0365-0596.
  4. Thapa, Sushma; Ghosh, Arnab; Shrestha, Santosh; Ghartimagar, Dilasma; Narasimhan, Raghavan; Talwar, OP (2017). “Warty Carcinoma Penis: An Uncommon Variant”. Case Reports in Pathology. 2017: 1–4. doi:10.1155/2017/2937592. ISSN 2090-6781.
  5. Hakenberg, Oliver Walther; Dräger, Desiree Louise; Erbersdobler, Andreas; Naumann, Carsten Maik; Jünemann, Klaus-Peter; Protzel, Chris (2018). “The diagnosis and treatment of penile cancer”. Deutsches Aerzteblatt Online. doi:10.3238/arztebl.2018.0646. ISSN 1866-0452.


Template:WikiDoc Sources

Pathophysiology

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

On gross pathology, the glans and the foreskin are the most common locations to find scaly patches, nodules, palpable painless lump, erythematous, ulceration, concurrent phimosis may conceal the lesion, surface of the lesion may be exophytic, flat, or ulcerated, chronic penile rash or subtle burning sensation and swollen inguinal lymph nodes as characteristic findings of carcinoma of penis. On microscopic histopathological analysis, keratinization and intercellular bridges are characteristic findings of carcinoma of the penis.

Pathogenesis

Grossly noted growth patterns include:

  1. Superficial spreading: tumors are limited to lamina propria or superficial corpus spongiosum.
    1. Usually extend horizontally through multiple anatomical compartments
  2. Vertical growth: tumors invade deep anatomical levels, surface is non-verruciform and frequently ulcerated
  3. Verruciform: tumors are exophytic and papillomatous with a cauliflower-like aspect.
    1. May be limited to surface (verrucous) or invade deep anatomical levels (cuniculatum)
  4. Mixed patterns: observed in 10 – 15% of all cases

On microscopic histopathological analysis, characteristic findings of carcinoma of the penis include:

Grading:

Gross & Microscopic Pathology

HPV-related Penile Carcinoma

Non-HPV related Penile Carcinoma

Microscopic Pathology

Grades of penile cancer

Grade Definition
GX Grade of differentiation cannot be assessed
G1 Well differentiated or low grade
G2 Moderately well differentiated or moderate grade
G3 Poorly differentiated or high grade
G4 Undifferentiated or high grade

References

  1. Spiess, Philippe (2013). Penile cancer : diagnosis and treatment. New York: Humana Press. ISBN 978-1-4939-6679-0.
  2. Spiess, Philippe E.; Dhillon, Jasreman; Baumgarten, Adam S.; Johnstone, Peter A.; Giuliano, Anna R. (2016). “Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies”. CA: A Cancer Journal for Clinicians. 66 (6): 481–495. doi:10.3322/caac.21354. ISSN 0007-9235.
  3. Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ (2009). “Penile cancer: epidemiology, pathogenesis and prevention”. World J Urol. 27 (2): 141–50. doi:10.1007/s00345-008-0302-z. PMID 18607597.
  4. Cubilla AL (2009). “The role of pathologic prognostic factors in squamous cell carcinoma of the penis”. World J Urol. 27 (2): 169–77. doi:10.1007/s00345-008-0315-7. PMID 18766352.
  5. “StatPearls”. 2019. PMID 29763105.
  6. Renaud-Vilmer C, Cavelier-Balloy B, Verola O, Morel P, Servant JM, Desgrandchamps F; et al. (2010). “Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma”. J Am Acad Dermatol. 62 (2): 284–90. doi:10.1016/j.jaad.2009.06.087. PMID 20115951.
  7. “Squamous cell carcinoma of the penis.Libre Pathology 2015”.
  8. “Grades of penile cancer.Canadian Cancer Society 2015”.


Template:WikiDoc Sources

Causes

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753, Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis is most commonly caused by an infection with human papillomavirus, lack of circumcision, phimosis, smegma, smoking and other tobacco use, UV light treatment of psoriasis as well as immunocompromised states such as AIDS.

Cause

Human papillomavirus[1] [2]

Lack of Circumcision

Phimosis

Smegma

Smoking and other tobacco use

UV light treatment for psoriasis

Immunocompromised states Poor genital hygiene

References


Template:WikiDoc Sources

Differentiating Carcinoma of the Penis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis must be differentiated from condyloma acuminata, penile intraepithelial neoplasia (PeIN), balanitis xerotica obliterans, buschke-Lowenstein tumour, bowenoid papulosis, and leukoplakia.

Differential Diagnosis

Carcinoma of the penis must be differentiated from:[1][2]

References

  1. Precancerous conditions of the penis. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/penile-cancer/precancerous-conditions/?region=ab Accessed on September, 30 2015
  2. Differential diagnoses of penile cancer. Oncology Encyclopedia 2015.http://oncolex.org/penile-cancer/background/differentialdiagnoses Accessed on September, 30 2015
  3. “Differential diagnoses of penile cancer”.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The incidence of carcinoma of the penis is approximately 1 per 100,000 males in the United States. The majority of cases are reported in less developed areas. The incidence of carcinoma of the penis increases with age; the median age at diagnosis is 60 years.

Epidemiology and Demographics

Incidence

  • Penile cancer is a malignancy that is rare in the Western Hemisphere [1] [2]
  • The incidence of carcinoma of the penis is approximately 1 per 100,000 males in the United States
  • Penile cancer accounts for 0.4–0.6% of malignant diagnoses in the USA and Europe, and is responsible for 0.1% of cancer deaths
  • The incidence is significantly higher in developing countries where penile cancer constitutes a significant public health hazard
  • Two pathways have been proposed for penile cancer development—one related to HPV infection and the other related to phimosis and/or chronic inflammation

Age

The incidence of carcinoma of the penis increases with age; the median age at diagnosis is 60 years.[3][4]

Race

Carcinoma of the penis usually affects individuals of the white, African American, and Hispanic race. Asian males are less likely to develop carcinoma of the penis.[3]

Developing Countries

The majority of carcinoma of the penis cases are reported in less developed areas, such as Africa, Asia, and South America.[5]

References

  1. Pow-Sang, Mariela R.; Ferreira, Ubirajara; Pow-Sang, Julio M.; Nardi, Aguinaldo C.; Destefano, Victor (2010). “Epidemiology and Natural History of Penile Cancer”. Urology. 76 (2): S2–S6. doi:10.1016/j.urology.2010.03.003. ISSN 0090-4295.
  2. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/penile/hp Accessed on Septermber, 30 2015
  3. 3.0 3.1 Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB; et al. (2008). “Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003”. Cancer. 113 (10 Suppl): 2883–91. doi:10.1002/cncr.23743. PMC 2693711. PMID 18980292.
  4. Hegarty PK, Kayes O, Freeman A, Christopher N, Ralph DJ, Minhas S (2006). “A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines”. BJU Int. 98 (3): 526–31. doi:10.1111/j.1464-410X.2006.06296.x. PMID 16925747.
  5. Siegel RL, Miller KD, Jemal A (2015). “Cancer statistics, 2015”. CA Cancer J Clin. 65 (1): 5–29. doi:10.3322/caac.21254. PMID 25559415.

Template:WH Template:WS

Risk Factors

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

Common risk factors in the development of carcinoma of the penis are human papillomavirus, phimosis, poor genital hygiene, uncircumcised males, weakened immune system, smoking, and PUVA treatment for psoriasis.

Risk factors

Common risk factors in the development of carcinoma of the penis include:[1]

References

  1. Risk factors for penile cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/risks/?region=ab


Template:WikiDoc Sources

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Swathi Venkatesan, M.B.B.S.[2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for carcinoma of the penis.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for carcinoma of the penis.[1]

References

  1. Bladder Cancer. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=penile+cancer

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine

Overview

Prognosis of carcinoma of the penis is generally good, and the 5-year survival rate is approximately 67%. The prognosis varies with the stage of tumor; stages 0–II have the most favorable prognosis.

Prognosis

Prognosis is generally good, and the 5-year survival rate of patients with penile cancer is approximately 67%.[1]

Survival by stage

Stage Definition 5-year survival rate
Stages 0–II Within the penis 80-100%
Stage III and some stage IV Spread to nearby tissues or lymph nodes 40-80%
Some stage IV Spread to distant sites in the body 11%

The prognosis varies with the stage of tumor; stages 0–II have the most favorable prognosis.[2]

References

  1. Survival statistics for penile cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/prognosis-and-survival/survival-statistics/?region=ab Accessed on September, 30 2015
  2. Survival statistics for penile cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/prognosis-and-survival/survival-statistics/?region=ab Accessed on September, 30 2015


Template:WikiDoc Sources

Diagnosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Labratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy

Treatment

Treatment

Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Template:Tumors


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH